Nova Pharmaceutical Corp said U.S. Patent Office allowed patent bradykinin antagonist drug .
Nova said patent also filed country worldwide .
It said exclusive worldwide right patent first bradykinin blocking drug developed topical pain reliever nasal spry form treating common cold symptom .
Nova said Bradykinin powerful paing-producing substance body considered , based scientific evidence , initial stimulus pain .
Reuter & # 3 ; 